(NASDAQ: KALA) Kala Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 21.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.
Kala Bio's earnings in 2024 is -$38,717,000.On average, 2 Wall Street analysts forecast KALA's earnings for 2024 to be -$54,161,974, with the lowest KALA earnings forecast at -$57,917,142, and the highest KALA earnings forecast at -$50,406,805.
In 2025, KALA is forecast to generate -$30,732,485 in earnings, with the lowest earnings forecast at -$30,732,485 and the highest earnings forecast at -$30,732,485.